| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Schizophrenia | 26 | 2019 | 1018 | 6.29 | Why? |
| Depressive Disorder, Major | 15 | 2019 | 852 | 4.64 | Why? |
| Antipsychotic Agents | 13 | 2019 | 887 | 3.39 | Why? |
| Bipolar Disorder | 11 | 2019 | 744 | 3.33 | Why? |
| Memory Disorders | 5 | 2018 | 190 | 2.58 | Why? |
| Electroconvulsive Therapy | 6 | 2019 | 326 | 2.54 | Why? |
| Quality of Life | 20 | 2021 | 9820 | 2.48 | Why? |
| Mental Disorders | 15 | 2021 | 6742 | 2.17 | Why? |
| Depression | 30 | 2021 | 14116 | 2.09 | Why? |
| Memory, Episodic | 3 | 2017 | 39 | 2.00 | Why? |
| Depressive Disorder | 10 | 2021 | 1236 | 1.97 | Why? |
| China | 73 | 2021 | 50654 | 1.78 | Why? |
| Mental Health Services | 11 | 2021 | 3007 | 1.74 | Why? |
| Students | 11 | 2021 | 5255 | 1.66 | Why? |
| Cognitive Dysfunction | 6 | 2018 | 1389 | 1.61 | Why? |
| Sleep Initiation and Maintenance Disorders | 9 | 2021 | 1692 | 1.54 | Why? |
| Hospitals, Psychiatric | 6 | 2021 | 506 | 1.47 | Why? |
| Weight Gain | 3 | 2018 | 552 | 1.42 | Why? |
| Schizophrenic Psychology | 4 | 2018 | 198 | 1.42 | Why? |
| Workplace Violence | 2 | 2021 | 100 | 1.37 | Why? |
| Suicide, Attempted | 3 | 2019 | 599 | 1.35 | Why? |
| Observational Studies as Topic | 7 | 2019 | 1887 | 1.31 | Why? |
| Randomized Controlled Trials as Topic | 14 | 2019 | 10649 | 1.30 | Why? |
| Mental Health | 16 | 2021 | 15770 | 1.29 | Why? |
| Prevalence | 35 | 2021 | 25773 | 1.21 | Why? |
| Irritable Bowel Syndrome | 2 | 2018 | 175 | 1.21 | Why? |
| Sleep | 7 | 2021 | 2695 | 1.11 | Why? |
| Antidepressive Agents | 7 | 2018 | 509 | 1.10 | Why? |
| Drug Prescriptions | 7 | 2018 | 1062 | 1.07 | Why? |
| Pain | 2 | 2021 | 1084 | 0.97 | Why? |
| Behavior, Addictive | 3 | 2018 | 535 | 0.96 | Why? |
| Universities | 6 | 2021 | 4374 | 0.91 | Why? |
| Social Stigma | 2 | 2021 | 1049 | 0.90 | Why? |
| Anxiety Disorders | 7 | 2021 | 2290 | 0.89 | Why? |
| Psychotropic Drugs | 5 | 2020 | 396 | 0.87 | Why? |
| Sleep Wake Disorders | 5 | 2020 | 1463 | 0.84 | Why? |
| Metformin | 2 | 2018 | 640 | 0.82 | Why? |
| Internet | 6 | 2020 | 6204 | 0.80 | Why? |
| Inpatients | 4 | 2021 | 5161 | 0.80 | Why? |
| Polypharmacy | 2 | 2019 | 347 | 0.79 | Why? |
| Child, Abandoned | 1 | 2018 | 4 | 0.78 | Why? |
| Anesthetics, Dissociative | 1 | 2019 | 21 | 0.77 | Why? |
| Treatment Adherence and Compliance | 1 | 2021 | 194 | 0.76 | Why? |
| Lurasidone Hydrochloride | 1 | 2018 | 18 | 0.75 | Why? |
| Buspirone | 1 | 2017 | 4 | 0.74 | Why? |
| Minocycline | 1 | 2019 | 101 | 0.73 | Why? |
| Serotonin 5-HT1 Receptor Agonists | 1 | 2017 | 11 | 0.73 | Why? |
| Female | 93 | 2021 | 380317 | 0.73 | Why? |
| Sickness Impact Profile | 1 | 2018 | 56 | 0.72 | Why? |
| Male | 90 | 2021 | 367725 | 0.71 | Why? |
| Suicide | 4 | 2018 | 1500 | 0.70 | Why? |
| Selective Estrogen Receptor Modulators | 1 | 2018 | 65 | 0.70 | Why? |
| Mental Processes | 1 | 2017 | 19 | 0.70 | Why? |
| Ranitidine | 1 | 2017 | 27 | 0.70 | Why? |
| Impulsive Behavior | 1 | 2018 | 78 | 0.69 | Why? |
| Hyperprolactinemia | 1 | 2017 | 19 | 0.69 | Why? |
| Dopamine Agents | 1 | 2017 | 20 | 0.69 | Why? |
| Raloxifene Hydrochloride | 1 | 2018 | 91 | 0.69 | Why? |
| Neuropsychological Tests | 3 | 2018 | 954 | 0.69 | Why? |
| Humans | 132 | 2021 | 930598 | 0.69 | Why? |
| Menopause | 1 | 2019 | 136 | 0.69 | Why? |
| Elder Abuse | 1 | 2018 | 60 | 0.69 | Why? |
| Suicidal Ideation | 2 | 2017 | 1226 | 0.68 | Why? |
| Patient Rights | 1 | 2018 | 84 | 0.68 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 1261 | 0.67 | Why? |
| Mood Disorders | 2 | 2018 | 431 | 0.67 | Why? |
| Emergency Services, Psychiatric | 1 | 2020 | 175 | 0.67 | Why? |
| Checklist | 3 | 2018 | 714 | 0.67 | Why? |
| Ketamine | 1 | 2019 | 112 | 0.67 | Why? |
| Cyclooxygenase 2 Inhibitors | 1 | 2017 | 48 | 0.67 | Why? |
| Celecoxib | 1 | 2017 | 49 | 0.66 | Why? |
| Borderline Personality Disorder | 1 | 2017 | 44 | 0.65 | Why? |
| Depression, Postpartum | 1 | 2021 | 282 | 0.65 | Why? |
| Tai Ji | 1 | 2017 | 63 | 0.65 | Why? |
| Psychotherapy | 3 | 2020 | 747 | 0.65 | Why? |
| Community Mental Health Services | 1 | 2020 | 217 | 0.65 | Why? |
| Cross-Sectional Studies | 29 | 2021 | 53120 | 0.65 | Why? |
| Isoindoles | 1 | 2017 | 195 | 0.64 | Why? |
| Amantadine | 1 | 2017 | 79 | 0.63 | Why? |
| Postmenopause | 1 | 2018 | 160 | 0.62 | Why? |
| Poverty Areas | 1 | 2021 | 556 | 0.61 | Why? |
| Nerve Tissue Proteins | 1 | 2018 | 319 | 0.61 | Why? |
| Attitude to Health | 2 | 2021 | 2002 | 0.61 | Why? |
| Mental Competency | 1 | 2017 | 128 | 0.60 | Why? |
| Mentally Ill Persons | 1 | 2017 | 103 | 0.60 | Why? |
| Homeless Persons | 2 | 2017 | 1171 | 0.60 | Why? |
| Erythropoietin | 1 | 2017 | 167 | 0.59 | Why? |
| Cognition Disorders | 2 | 2018 | 574 | 0.58 | Why? |
| Life Style | 2 | 2018 | 2708 | 0.56 | Why? |
| Publications | 1 | 2020 | 463 | 0.56 | Why? |
| Databases, Factual | 9 | 2019 | 6248 | 0.55 | Why? |
| Piperazines | 1 | 2017 | 445 | 0.55 | Why? |
| Protective Agents | 1 | 2017 | 250 | 0.55 | Why? |
| Adult | 59 | 2021 | 244371 | 0.55 | Why? |
| Psychiatric Department, Hospital | 1 | 2018 | 253 | 0.54 | Why? |
| Smoking | 3 | 2018 | 3358 | 0.53 | Why? |
| Accidental Falls | 1 | 2018 | 448 | 0.51 | Why? |
| Stress Disorders, Post-Traumatic | 2 | 2020 | 2963 | 0.51 | Why? |
| Autism Spectrum Disorder | 2 | 2019 | 587 | 0.51 | Why? |
| Pediatric Obesity | 1 | 2019 | 492 | 0.51 | Why? |
| Middle Aged | 52 | 2021 | 270681 | 0.50 | Why? |
| Emigration and Immigration | 1 | 2018 | 501 | 0.50 | Why? |
| Surveys and Questionnaires | 22 | 2021 | 43792 | 0.49 | Why? |
| Overweight | 1 | 2019 | 916 | 0.48 | Why? |
| Health Priorities | 1 | 2021 | 959 | 0.47 | Why? |
| Consumer Health Information | 1 | 2021 | 750 | 0.47 | Why? |
| Health Personnel | 7 | 2021 | 29646 | 0.46 | Why? |
| Sex Characteristics | 2 | 2017 | 1120 | 0.46 | Why? |
| Mindfulness | 1 | 2018 | 437 | 0.46 | Why? |
| Epidemiologic Studies | 3 | 2018 | 554 | 0.45 | Why? |
| Civil Defense | 2 | 2020 | 1687 | 0.45 | Why? |
| Psychiatry | 2 | 2021 | 1289 | 0.45 | Why? |
| Psychometrics | 5 | 2018 | 1269 | 0.44 | Why? |
| Psychotic Disorders | 2 | 2018 | 924 | 0.44 | Why? |
| Drug Therapy, Combination | 5 | 2018 | 7268 | 0.41 | Why? |
| Cell Phone | 1 | 2018 | 750 | 0.41 | Why? |
| Interpersonal Relations | 1 | 2018 | 926 | 0.41 | Why? |
| Psychiatric Status Rating Scales | 6 | 2018 | 1340 | 0.40 | Why? |
| Analysis of Variance | 5 | 2021 | 950 | 0.40 | Why? |
| Pregnancy Complications | 1 | 2021 | 1388 | 0.39 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.39 | Why? |
| Health Communication | 1 | 2021 | 1120 | 0.39 | Why? |
| Pyrimidines | 1 | 2017 | 1557 | 0.39 | Why? |
| Aging | 4 | 2019 | 3581 | 0.39 | Why? |
| Hepatitis B virus | 1 | 2017 | 882 | 0.39 | Why? |
| Homosexuality, Male | 1 | 2018 | 1158 | 0.38 | Why? |
| Students, Nursing | 1 | 2021 | 1104 | 0.38 | Why? |
| Case-Control Studies | 11 | 2019 | 17671 | 0.37 | Why? |
| Health Knowledge, Attitudes, Practice | 3 | 2021 | 8811 | 0.36 | Why? |
| Hospitals, General | 3 | 2018 | 711 | 0.36 | Why? |
| Young Adult | 25 | 2021 | 93724 | 0.36 | Why? |
| Prisoners | 1 | 2017 | 738 | 0.35 | Why? |
| Resilience, Psychological | 2 | 2020 | 2329 | 0.35 | Why? |
| Transients and Migrants | 1 | 2020 | 1468 | 0.35 | Why? |
| Neuroticism | 2 | 2018 | 87 | 0.35 | Why? |
| Coronavirus Infections | 13 | 2020 | 253789 | 0.34 | Why? |
| Prisons | 1 | 2017 | 980 | 0.33 | Why? |
| Educational Status | 3 | 2018 | 1451 | 0.33 | Why? |
| Racism | 1 | 2020 | 1462 | 0.32 | Why? |
| Disease Outbreaks | 9 | 2020 | 27595 | 0.32 | Why? |
| Caregivers | 2 | 2018 | 3112 | 0.32 | Why? |
| Pneumonia, Viral | 12 | 2020 | 243684 | 0.32 | Why? |
| Neural Pathways | 2 | 2017 | 155 | 0.31 | Why? |
| Adolescent | 22 | 2021 | 86841 | 0.31 | Why? |
| Schools | 2 | 2020 | 4187 | 0.31 | Why? |
| Aged | 28 | 2021 | 215776 | 0.30 | Why? |
| Alcohol Drinking | 2 | 2018 | 1663 | 0.30 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.29 | Why? |
| Vulnerable Populations | 1 | 2020 | 3099 | 0.29 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.29 | Why? |
| Socioeconomic Factors | 3 | 2021 | 8495 | 0.28 | Why? |
| Nurses | 1 | 2020 | 2285 | 0.27 | Why? |
| Practice Patterns, Physicians' | 3 | 2018 | 4927 | 0.27 | Why? |
| Macau | 3 | 2019 | 116 | 0.27 | Why? |
| Stroke | 2 | 2018 | 8839 | 0.26 | Why? |
| Social Support | 1 | 2018 | 3183 | 0.26 | Why? |
| Self-Injurious Behavior | 2 | 2018 | 391 | 0.25 | Why? |
| Health Surveys | 3 | 2019 | 2841 | 0.25 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.24 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.24 | Why? |
| Liver Diseases | 1 | 2017 | 2698 | 0.22 | Why? |
| Brain Ischemia | 1 | 2016 | 2813 | 0.22 | Why? |
| Aged, 80 and over | 12 | 2020 | 88759 | 0.22 | Why? |
| Age Factors | 6 | 2020 | 21039 | 0.21 | Why? |
| Combined Modality Therapy | 3 | 2019 | 3395 | 0.21 | Why? |
| Pandemics | 17 | 2021 | 389249 | 0.21 | Why? |
| Inflammatory Bowel Diseases | 1 | 2018 | 3209 | 0.21 | Why? |
| Demography | 2 | 2018 | 1660 | 0.21 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.21 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.21 | Why? |
| Longitudinal Studies | 5 | 2021 | 9893 | 0.21 | Why? |
| Asia | 5 | 2019 | 2399 | 0.21 | Why? |
| Asia, Central | 1 | 2019 | 18 | 0.20 | Why? |
| Pitch Perception | 1 | 2019 | 1 | 0.20 | Why? |
| Anxiety | 6 | 2021 | 17311 | 0.20 | Why? |
| Anti-Inflammatory Agents | 1 | 2019 | 6153 | 0.20 | Why? |
| Brain Mapping | 2 | 2018 | 228 | 0.20 | Why? |
| Stress, Psychological | 2 | 2020 | 10231 | 0.20 | Why? |
| Rest | 2 | 2018 | 188 | 0.20 | Why? |
| Tranquilizing Agents | 1 | 2018 | 9 | 0.20 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.19 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.19 | Why? |
| Health Services Accessibility | 2 | 2020 | 10697 | 0.19 | Why? |
| Self Mutilation | 1 | 2018 | 3 | 0.19 | Why? |
| Tibet | 1 | 2018 | 80 | 0.19 | Why? |
| Brief Psychiatric Rating Scale | 1 | 2018 | 30 | 0.19 | Why? |
| Contingent Negative Variation | 1 | 2017 | 1 | 0.18 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.18 | Why? |
| Benzodiazepines | 2 | 2017 | 163 | 0.18 | Why? |
| Logistic Models | 4 | 2021 | 9089 | 0.18 | Why? |
| Quarantine | 3 | 2020 | 18418 | 0.18 | Why? |
| Aggression | 1 | 2019 | 126 | 0.18 | Why? |
| Marijuana Smoking | 1 | 2019 | 80 | 0.18 | Why? |
| Acrylamide | 1 | 2017 | 24 | 0.18 | Why? |
| Adult Survivors of Child Abuse | 1 | 2018 | 34 | 0.18 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.18 | Why? |
| Double-Blind Method | 3 | 2018 | 5988 | 0.17 | Why? |
| Hospitalization | 3 | 2018 | 54280 | 0.17 | Why? |
| Physical Abuse | 1 | 2018 | 78 | 0.17 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2019 | 6166 | 0.17 | Why? |
| Child | 10 | 2021 | 70012 | 0.17 | Why? |
| Sexual Harassment | 1 | 2018 | 62 | 0.17 | Why? |
| Time Factors | 6 | 2017 | 31397 | 0.17 | Why? |
| Outpatients | 3 | 2020 | 3417 | 0.17 | Why? |
| Network Meta-Analysis | 1 | 2020 | 426 | 0.17 | Why? |
| Odds Ratio | 3 | 2019 | 5861 | 0.17 | Why? |
| Conduct Disorder | 1 | 2017 | 39 | 0.17 | Why? |
| Cholinergic Antagonists | 1 | 2017 | 56 | 0.17 | Why? |
| Marital Status | 1 | 2018 | 186 | 0.17 | Why? |
| Age of Onset | 1 | 2019 | 557 | 0.17 | Why? |
| Kruppel-Like Transcription Factors | 1 | 2017 | 91 | 0.17 | Why? |
| Mental Status and Dementia Tests | 1 | 2018 | 208 | 0.17 | Why? |
| Smartphone | 2 | 2020 | 1840 | 0.17 | Why? |
| Prolactin | 1 | 2017 | 68 | 0.17 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2021 | 12361 | 0.17 | Why? |
| Antimanic Agents | 1 | 2017 | 54 | 0.16 | Why? |
| Prejudice | 1 | 2020 | 245 | 0.16 | Why? |
| Speech Perception | 1 | 2019 | 132 | 0.16 | Why? |
| Prefrontal Cortex | 1 | 2018 | 151 | 0.16 | Why? |
| Criminals | 1 | 2017 | 56 | 0.16 | Why? |
| Crisis Intervention | 1 | 2020 | 229 | 0.16 | Why? |
| Telemedicine | 4 | 2020 | 25032 | 0.16 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.16 | Why? |
| Parent-Child Relations | 1 | 2020 | 384 | 0.16 | Why? |
| Remission Induction | 2 | 2017 | 950 | 0.16 | Why? |
| Models, Psychological | 1 | 2020 | 383 | 0.16 | Why? |
| Hotlines | 1 | 2020 | 337 | 0.16 | Why? |
| Social Discrimination | 1 | 2020 | 269 | 0.16 | Why? |
| Factor Analysis, Statistical | 1 | 2018 | 538 | 0.15 | Why? |
| Japan | 3 | 2018 | 6653 | 0.15 | Why? |
| Disabled Children | 1 | 2018 | 178 | 0.15 | Why? |
| Statistics as Topic | 1 | 2018 | 370 | 0.15 | Why? |
| Family Relations | 1 | 2018 | 288 | 0.14 | Why? |
| Developed Countries | 1 | 2019 | 500 | 0.14 | Why? |
| Cannabis | 1 | 2019 | 284 | 0.14 | Why? |
| Access to Information | 1 | 2020 | 483 | 0.14 | Why? |
| Comorbidity | 5 | 2021 | 34796 | 0.14 | Why? |
| Clozapine | 1 | 2018 | 218 | 0.14 | Why? |
| Health Plan Implementation | 1 | 2020 | 571 | 0.14 | Why? |
| Personality | 1 | 2018 | 277 | 0.14 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.14 | Why? |
| Cross-Cultural Comparison | 1 | 2017 | 338 | 0.14 | Why? |
| North America | 1 | 2019 | 1400 | 0.14 | Why? |
| Models, Organizational | 1 | 2020 | 908 | 0.14 | Why? |
| Goals | 1 | 2017 | 335 | 0.14 | Why? |
| Placebos | 1 | 2017 | 629 | 0.14 | Why? |
| Activities of Daily Living | 3 | 2018 | 1530 | 0.14 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.13 | Why? |
| Hong Kong | 3 | 2018 | 3361 | 0.13 | Why? |
| Neurodevelopmental Disorders | 1 | 2018 | 284 | 0.13 | Why? |
| Health Care Reform | 1 | 2020 | 409 | 0.13 | Why? |
| Transportation | 1 | 2020 | 691 | 0.13 | Why? |
| Self Concept | 1 | 2018 | 490 | 0.13 | Why? |
| Self Report | 4 | 2018 | 3802 | 0.13 | Why? |
| Outpatient Clinics, Hospital | 1 | 2018 | 523 | 0.13 | Why? |
| Delivery of Health Care | 1 | 2019 | 15909 | 0.12 | Why? |
| Nursing Homes | 3 | 2018 | 4155 | 0.12 | Why? |
| Chronic Disease | 2 | 2017 | 5139 | 0.12 | Why? |
| Social Class | 2 | 2018 | 1360 | 0.12 | Why? |
| Mass Media | 1 | 2021 | 837 | 0.11 | Why? |
| Treatment Outcome | 5 | 2019 | 51732 | 0.11 | Why? |
| Drug Utilization | 1 | 2017 | 619 | 0.11 | Why? |
| Risk Factors | 8 | 2019 | 71621 | 0.11 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.11 | Why? |
| Independent Living | 1 | 2018 | 842 | 0.11 | Why? |
| Rural Population | 3 | 2018 | 2408 | 0.11 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.11 | Why? |
| Cognition | 2 | 2017 | 1394 | 0.11 | Why? |
| Violence | 1 | 2017 | 534 | 0.11 | Why? |
| Attitude | 1 | 2020 | 1481 | 0.10 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.10 | Why? |
| Needs Assessment | 1 | 2020 | 2352 | 0.10 | Why? |
| Cerebrovascular Disorders | 1 | 2018 | 1040 | 0.10 | Why? |
| Brain | 2 | 2017 | 5133 | 0.10 | Why? |
| Geriatric Assessment | 1 | 2018 | 1372 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.09 | Why? |
| Emotions | 2 | 2018 | 2418 | 0.09 | Why? |
| Personnel, Hospital | 1 | 2021 | 2273 | 0.08 | Why? |
| Periodicals as Topic | 1 | 2020 | 1492 | 0.08 | Why? |
| Employment | 1 | 2018 | 1754 | 0.08 | Why? |
| Parents | 1 | 2020 | 2758 | 0.08 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.08 | Why? |
| Qualitative Research | 1 | 2018 | 4337 | 0.08 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.07 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.07 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.07 | Why? |
| Research | 1 | 2018 | 2115 | 0.07 | Why? |
| Diet | 1 | 2017 | 2052 | 0.07 | Why? |
| Fear | 1 | 2020 | 3607 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
| Developing Countries | 1 | 2019 | 4283 | 0.06 | Why? |
| Symptom Assessment | 1 | 2017 | 4967 | 0.06 | Why? |
| Europe | 1 | 2019 | 12702 | 0.06 | Why? |
| Communication | 1 | 2020 | 5206 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Electroencephalography | 2 | 2019 | 1242 | 0.05 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.05 | Why? |
| Regression Analysis | 2 | 2018 | 2484 | 0.05 | Why? |
| Evoked Potentials, Auditory | 1 | 2019 | 34 | 0.05 | Why? |
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2018 | 29 | 0.05 | Why? |
| Social Media | 1 | 2021 | 5798 | 0.05 | Why? |
| Speech Disorders | 1 | 2018 | 55 | 0.05 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.05 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.05 | Why? |
| Hearing Disorders | 1 | 2018 | 62 | 0.04 | Why? |
| Basal Ganglia Diseases | 1 | 2017 | 16 | 0.04 | Why? |
| Reaction Time | 1 | 2017 | 96 | 0.04 | Why? |
| Sleep Hygiene | 1 | 2018 | 91 | 0.04 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Telomere Homeostasis | 1 | 2017 | 52 | 0.04 | Why? |
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2018 | 184 | 0.04 | Why? |
| Connectome | 1 | 2017 | 67 | 0.04 | Why? |
| Visual Perception | 1 | 2017 | 49 | 0.04 | Why? |
| Spectroscopy, Near-Infrared | 1 | 2018 | 137 | 0.04 | Why? |
| Cues | 1 | 2017 | 86 | 0.04 | Why? |
| Food Contamination | 1 | 2017 | 142 | 0.04 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3832 | 0.04 | Why? |
| Nutrition Surveys | 1 | 2017 | 287 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Beijing | 1 | 2018 | 912 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Residence Characteristics | 2 | 2017 | 1927 | 0.04 | Why? |
| Prospective Studies | 2 | 2017 | 43301 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.04 | Why? |
| Sex Factors | 3 | 2017 | 11014 | 0.03 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.03 | Why? |
| Counseling | 1 | 2020 | 747 | 0.03 | Why? |
| Interview, Psychological | 1 | 2013 | 68 | 0.03 | Why? |
| Language | 1 | 2019 | 655 | 0.03 | Why? |
| Intellectual Disability | 1 | 2018 | 391 | 0.03 | Why? |
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 441 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.03 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.03 | Why? |
| Protective Factors | 1 | 2018 | 1720 | 0.03 | Why? |
| Magnetic Resonance Imaging | 2 | 2017 | 6551 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Taiwan | 1 | 2018 | 2556 | 0.03 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.02 | Why? |
| Singapore | 1 | 2018 | 3641 | 0.02 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.02 | Why? |
| Mass Screening | 2 | 2018 | 8005 | 0.02 | Why? |
| Urban Population | 1 | 2017 | 2000 | 0.02 | Why? |
| Republic of Korea | 1 | 2018 | 5858 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.02 | Why? |
| Emergency Medical Services | 1 | 2020 | 3557 | 0.02 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |